Union Budget 2026: ₹10,000 Crore Boost for Biopharma Shakti Over 5 Years

• Finance Minister Nirmala Sitharaman announced ₹10,000 crore for Biopharma Shakti over the next five years in the Union Budget 2026.
• The initiative aims to build an ecosystem for domestic production of biologics and biosimilars, crucial for India's health and innovation future.
• Strategy includes a biopharma-focused network with three new NIPERs, upgrading seven existing ones, and creating 1,000 accredited Indian clinical trial sites.
• Proposals also include strengthening the Central Drug Standard Control Organisation and establishing five regional medical hubs combining medical, educational, and research facilities.
• Industry leaders like Kiran Mazumdar Shaw and Dr. Saurabh Arora lauded the budget's focus on biopharma, emphasizing its potential to position India as a global manufacturing hub.

Why It Matters: Union Budget 2026 allocates ₹10,000 crore to boost India's biopharma sector, fostering domestic production and research.